Torsdag 12 November | 15:59:00 Europe / Stockholm
Est. tid*
2027-02-23 08:00 Bokslutskommuniké 2026
2026-11-26 08:30 Kvartalsrapport 2026-Q3
2026-08-19 - Kvartalsrapport 2026-Q2
2026-06-24 - Årsstämma
2026-05-27 - Kvartalsrapport 2026-Q1
2026-05-08 - X-dag ordinarie utdelning PMED 0.00 SEK
2026-02-27 - Bokslutskommuniké 2025
2025-11-06 - Kvartalsrapport 2025-Q3
2025-08-13 - Kvartalsrapport 2025-Q2
2025-06-26 - Årsstämma
2025-05-28 - Kvartalsrapport 2025-Q1
2025-05-21 - X-dag ordinarie utdelning PMED 0.00 SEK
2025-02-28 - Bokslutskommuniké 2024
2025-01-07 - Extra Bolagsstämma 2024
2024-11-06 - Kvartalsrapport 2024-Q3
2024-08-15 - Kvartalsrapport 2024-Q2
2024-05-22 - X-dag ordinarie utdelning PMED 0.00 SEK
2024-05-21 - Årsstämma
2024-05-07 - Kvartalsrapport 2024-Q1
2024-02-23 - Bokslutskommuniké 2023
2024-01-11 - Extra Bolagsstämma 2023
2023-10-24 - Kvartalsrapport 2023-Q3
2023-08-11 - Kvartalsrapport 2023-Q2
2023-04-24 - Kvartalsrapport 2023-Q1
2023-04-21 - X-dag ordinarie utdelning PMED 0.00 SEK
2023-04-20 - Årsstämma
2023-02-24 - Bokslutskommuniké 2022
2023-01-09 - Extra Bolagsstämma 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-08-18 - Kvartalsrapport 2022-Q2
2022-05-25 - X-dag ordinarie utdelning PMED 0.00 SEK
2022-05-24 - Årsstämma
2022-05-12 - Kvartalsrapport 2022-Q1
2022-02-25 - Bokslutskommuniké 2021
2021-12-16 - Extra Bolagsstämma 2021
2021-11-10 - Kvartalsrapport 2021-Q3
2021-08-18 - Kvartalsrapport 2021-Q2
2021-06-10 - X-dag ordinarie utdelning PMED 0.00 SEK
2021-05-27 - Årsstämma
2021-05-12 - Kvartalsrapport 2021-Q1
2021-02-26 - Bokslutskommuniké 2020
2020-11-10 - Kvartalsrapport 2020-Q3
2020-08-17 - Kvartalsrapport 2020-Q2
2020-07-28 - Extra Bolagsstämma 2020
2020-06-30 - Årsstämma
2020-06-17 - X-dag ordinarie utdelning PMED 0.00 SEK
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-27 - Bokslutskommuniké 2019
2019-11-08 - Kvartalsrapport 2019-Q3
2019-08-16 - Kvartalsrapport 2019-Q2
2019-06-20 - X-dag ordinarie utdelning PMED 0.00 SEK
2019-06-19 - Årsstämma
2019-05-15 - Kvartalsrapport 2019-Q1
2019-02-27 - Bokslutskommuniké 2018
2018-11-09 - Kvartalsrapport 2018-Q3
2018-08-17 - Kvartalsrapport 2018-Q2
2018-05-15 - Kvartalsrapport 2018-Q1
2018-03-29 - X-dag ordinarie utdelning PMED 0.00 SEK
2018-03-28 - Årsstämma
2018-02-27 - Bokslutskommuniké 2017
2017-11-09 - Kvartalsrapport 2017-Q3
2017-08-17 - Kvartalsrapport 2017-Q2
2017-05-19 - X-dag ordinarie utdelning PMED 0.00 SEK
2017-05-18 - Årsstämma
2017-05-16 - Kvartalsrapport 2017-Q1
2017-02-27 - Bokslutskommuniké 2016
2016-11-10 - Kvartalsrapport 2016-Q3
2016-08-17 - Kvartalsrapport 2016-Q2
2016-07-22 - Extra Bolagsstämma 2016
2016-05-20 - X-dag ordinarie utdelning PMED 0.00 SEK
2016-05-19 - Årsstämma
2016-05-17 - Kvartalsrapport 2016-Q1
2016-02-26 - Bokslutskommuniké 2015
2015-11-19 - Extra Bolagsstämma 2015
2015-11-11 - Kvartalsrapport 2015-Q3
2015-08-17 - Kvartalsrapport 2015-Q2
2015-05-08 - Kvartalsrapport 2015-Q1
2015-04-10 - X-dag ordinarie utdelning PMED 0.00 SEK
2015-04-09 - Årsstämma
2015-02-27 - Bokslutskommuniké 2014
2014-10-15 - Kvartalsrapport 2014-Q3
2014-08-13 - Kvartalsrapport 2014-Q2
LandSverige
ListaSpotlight
SektorHälsovård
IndustriBioteknik
Peptonic Medical är ett biomedicinskt bolag som bedriver forskning kring och utveckling av läkemedel och medicintekniska produkter inom området kvinnohälsa. Bolagets vision är att erbjuda behandlingar för kvinnospecifika sjukdomar och medicinska tillstånd. Exempelvis sker utveckling av hormonfria produkter för behandling av vaginal atrofi och vaginal torrhet. Peptonic Medical har sitt huvudkontor i Bromma.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Peptonic launches VagiVital Intimate V Wipes - first pharmacy order

2026-11-03 10:45:00

Peptonic Medical AB (publ) ("Peptonic" or "the Company") announces that its new product, VagiVital Intimate V Wipes, will be launched on the Swedish market in November. The first pharmacy order has already been placed, with delivery scheduled for mid-November. The launch represents a further step in Peptonic's commercial strategy to broaden the VagiVital product portfolio, strengthen the brand's market position, and create new sales opportunities within intimate health and self-care.  

VagiVital Intimate V Wipes complement the Company's existing range and have been developed for gentle and practical intimate cleansing. V Wipes are individually wrapped and offer a convenient solution for daily intimate care, whether you're on the go, at home or travelling. V Wipes contain moisturizing glycerine and a pre- and probiotic complex that helps to support the natural balance of the intimate area. 

The launch will initially take place through VagiVital's own sales channels and pharmacies. By expanding its range with products that meet recurring consumer needs, Peptonic aims to reach new target groups, increase purchase frequency, and create opportunities for increased sales. 

"V Wipes is an important addition to our product portfolio and strengthens our offering in daily intimate care. The fact that the first pharmacy order has already been placed ahead of the launch is a positive indication of commercial interest. We see good opportunities to reach more consumers, broaden our distribution and continue to develop VagiVital into a stronger brand within women's health and wellbeing," says Daniel Rudeklint, interim CEO of Peptonic Medical AB.  

The other two new products previously announced: VagiVital Intimate Moisturizing Cream and the dietary supplement VagiVital Active Balance, will be launched later this autumn. 

For further information, please contact:  

Daniel Rudeklint 

Interim CEO, Peptonic Medical AB 

Email:daniel.rudeklint@peptonicmedical.se  

Telephone: +46 73 158 02 73  

About Peptonic Medical AB 

Peptonic Medical AB (publ) is a Swedish company specialising in women's health that develops and sells products for intimate self-care, health and wellbeing. The company's strategy is based on developing a broad product portfolio under its own brands, combined with international expansion through strategic distribution and brand partners. Peptonic Medical is listed on the Spotlight Stock Market.